Role of the vitamin K epoxide reductase complex subunit 1 (VKORC1) -1639G>A gene polymorphism in patients with retinal vein occlusion.

doi:10.3109/02713683.2013.820329

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Role of the vitamin K epoxide reductase complex subunit 1 (VKORC1) -1639G>A gene polymorphism in patients with retinal vein occlusion.

Current eye research - 1 Dec 2013

Weger Martin, Steinbrugger Iris, Renner Wilfried, Pöschl Eva Maria, Brockmann Tobias, Rabensteiner Dieter Franz, El-Shabrawi Yosuf, Haas Anton

Abstract excerpt

PURPOSE OF THE STUDY: Retinal vein occlusion (RVO) is a major vision-threatening disease. Vitamin K epoxide reductase recycles reduced vitamin K, which is essential for the gamma carboxylation of clotting factors II, VII, IX, X and proteins C and S. Recently, the vitamin K epoxide reductase complex subunit 1 (VKORC1) -1639G>A (rs9923231) polymorphism has been reported as a novel risk factor for RVO in a Turkish...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Aged, 80 and over

Share to Case-Control Studies

Share to Logistic Models

Share to Retinal Vein Occlusion

Share to Risk Factors

Share to Vitamin K

Share to Vitamin K Epoxide Reductases

Source

Open in PubMed

Identifiers

PMID: 23972066
DOI: 10.3109/02713683.2013.820329

Genes

VKORC1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Role of the vitamin K epoxide reductase complex subunit 1 (VKORC1) -1639G>A gene polymorphism in patients with retinal vein occlusion.PMID 23972066Read ↗

Predictive value of the vitamin K epoxide reductase complex subunit 1 G-1639A and C1173T single nucleotide polymorphisms in retinal vein occlusion.Semantic proximity Read ↗

Thrombophilic risk factors in different types of retinal vein occlusion in Tunisian patients.Semantic proximity Read ↗

[Retinal vascular occlusion and polymorphisms in genes coding for components of vitamin K cycle].Semantic proximity Read ↗

Genetic polymorphisms associated with retinal vein occlusion: a Greek case-control study and meta-analysis.Semantic proximity Read ↗

G-1639A but Not C1173T VKORC1 Gene Polymorphism Is Related to Ischemic Stroke and Its Various Risk Factors in Ukrainian Population.Semantic proximity Read ↗

VKORC1 C1173T and VKORC1 G-1639A gene polymorphisms in Turkish Behçet's patients with ocular and non-ocular involvement.Semantic proximity Read ↗

Stromal Cell-Derived Factor 1 Polymorphism in Retinal Vein Occlusion.Semantic proximity Read ↗

Association of methylenetetrahydrofolate reductase (A1298C and C677T) polymorphisms with retinal vein occlusion in Tunisian patients.Semantic proximity Read ↗

Genetic polymorphisms and retinal vein occlusion in an Italian population.Semantic proximity Read ↗

PON1, APOE and SDF-1 Gene Polymorphisms and Risk of Retinal Vein Occlusion: A Case-Control Study.Semantic proximity Read ↗

Retinal vein occlusion: genetic predisposition and systemic risk factors.Semantic proximity Read ↗

Increased prevalence of factor V Leiden in patients with retinal vein occlusion and under 60 years of age.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.